Access to anti-retroviral drugs, female (%) in Mongolia
Mongolia: Access to anti-retroviral drugs, female (%) was 36.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Mongolia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Mongolia is 36.0%, measured in 2024.
The figure is up 44.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Mongolia peaked at 42.0% in 2021 and was at its lowest, 0.0%, in 2000.
That places Mongolia 130th out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female (%) in Mongolia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 6.0% | — |
| 2004 | 4.0% | -33.3% |
| 2005 | 0.0% | -100.0% |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 2.0% | — |
| 2010 | 7.0% | +250.0% |
| 2011 | 13.0% | +85.7% |
| 2012 | 12.0% | -7.7% |
| 2013 | 18.0% | +50.0% |
| 2014 | 25.0% | +38.9% |
| 2015 | 33.0% | +32.0% |
| 2016 | 30.0% | -9.1% |
| 2017 | 34.0% | +13.3% |
| 2018 | 33.0% | -2.9% |
| 2019 | 36.0% | +9.1% |
| 2020 | 40.0% | +11.1% |
| 2021 | 42.0% | +5.0% |
| 2022 | 40.0% | -4.8% |
| 2023 | 36.0% | -10.0% |
| 2024 | 36.0% | +0.0% |
Mongolia compared with similar countries
- Mongolia's 36.0% is below the median for upper middle income countries, which is 65.0%, 55% of the median. (39 countries reporting)
- Mongolia's 36.0% is below the median for East Asia & Pacific, which is 71.0%, 51% of the median. (15 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female (%) in Mongolia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2010 | +250.0% | 2.0% | 7.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.2% | 0.0% | 6.0% | 10 |
| 2010s | 24.1% | 7.0% | 36.0% | 10 |
| 2020s | 38.8% | 36.0% | 42.0% | 5 |
Countries ranked near Mongolia
More gender data for Mongolia
- Child population (UN estimates and projections) 1,010 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.54 % change on previous year (2030)
- Population 2,695 (2030)
- Working-age population (UN estimates and projections) 2,695 (2030)
- Population (UN estimates and projections), annual growth rate 2.37 % change on previous year (2030)
- Age population, age 00, female, interpolated 30,279 (2025)
- Age population, age 00, male, interpolated 31,506 (2025)
- Age population, age 01, female, interpolated 31,061 (2025)
- Age population, age 01, male, interpolated 32,353 (2025)
- Age population, age 02, female, interpolated 31,994 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Mongolia?
- Access to anti-retroviral drugs, female in Mongolia was 36.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Mongolia?
- The highest recorded value was 42.0% in 2021.
- What is the lowest access to anti-retroviral drugs, female recorded in Mongolia?
- The lowest recorded value was 0.0% in 2000.
- How does Mongolia rank for access to anti-retroviral drugs, female?
- Mongolia ranks 130th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Mongolia?
- Over the last ten years it is up 44.0%. The long-run trend across the full record is volatile.
- Where does this Mongolia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.